Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction | Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
Ambrose KristenSVP & CAO |
Sell | 883 @ $425.70 | $375,893 | 7,965 | 02/26/2024 | 02/27/2024 | |
ALTSHULER DAVIDEVP, Global Research and CSO |
Sell | 4,239 @ $425.70 | $1.80 M | 25,813 | 02/26/2024 | 02/27/2024 | |
Tatsis OuraniaEVP, Chief Reg. & Quality Off. |
Sell | 360 @ $421.77 | $151,837 | 59,467 | 02/21/2024 | 02/23/2024 | |
Sachdev AmitEVP Chief Patient & Ext Af Off |
Sell | 3,191 @ $421.77 | $1.35 M | 60,798 | 02/21/2024 | 02/23/2024 | |
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. |
Sell | 1,201 @ $421.77 | $506,546 | 18,509 | 02/21/2024 | 02/23/2024 | |
Arbuckle Stuart AEVP, COO |
Sell | 3,603 @ $421.77 | $1.52 M | 59,439 | 02/21/2024 | 02/23/2024 | |
ALTSHULER DAVIDEVP, Global Research and CSO |
Sell | 3,002 @ $421.77 | $1.27 M | 34,022 | 02/21/2024 | 02/23/2024 | |
Tatsis OuraniaEVP, Chief Reg. & Quality Off. |
Sell | 480 @ $420.79 | $201,979 | 59,827 | 02/20/2024 | 02/21/2024 | |
Sachdev AmitEVP Chief Patient & Ext Af Off |
Sell | 4,254 @ $420.79 | $1.79 M | 63,989 | 02/20/2024 | 02/21/2024 | |
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. |
Sell | 801 @ $420.79 | $337,053 | 19,710 | 02/20/2024 | 02/21/2024 | |
Arbuckle Stuart AEVP, COO |
Sell | 4,804 @ $420.79 | $2.02 M | 63,042 | 02/20/2024 | 02/21/2024 | |
ALTSHULER DAVIDEVP, Global Research and CSO |
Sell | 4,002 @ $420.79 | $1.68 M | 37,024 | 02/20/2024 | 02/21/2024 | |
LEIDEN JEFFREY Mdirector, Executive Chairman |
Sell | 4,655 @ $419.16 | $1.95 M | 17,896 | 02/15/2024 | 02/16/2024 | |
LEIDEN JEFFREY Mdirector, Executive Chairman |
Sell | 4,356 @ $419.04 | $1.83 M | 22,551 | 02/14/2024 | 02/16/2024 | |
LEIDEN JEFFREY Mdirector, Executive Chairman |
Sell | 737 @ $419.13 | $308,899 | 26,907 | 02/13/2024 | 02/14/2024 | |
LEIDEN JEFFREY Mdirector, Executive Chairman |
Sell | 2,009 @ $419.22 | $842,213 | 28,291 | 02/12/2024 | 02/14/2024 | |
LEIDEN JEFFREY Mdirector, Executive Chairman |
Sell | 647 @ $420.39 | $271,992 | 27,644 | 02/12/2024 | 02/14/2024 | |
Tatsis OuraniaEVP, Chief Reg. & Quality Off. |
Sell | 314 @ $420.24 | $131,955 | 68,179 | 02/12/2024 | 02/13/2024 | |
Sachdev AmitEVP Chief Patient & Ext Af Off |
Sell | 3,222 @ $420.24 | $1.35 M | 74,364 | 02/12/2024 | 02/13/2024 | |
Biller JonathanEVP and Chief Legal Officer |
Sell | 1,738 @ $418.77 | $727,822 | 18,280 | 02/12/2024 | 02/13/2024 |
Member of congress | Current Price | Type | Trade Data | Date Filed | Date Traded |
---|---|---|---|---|---|
$477.87 | Sale (Full) | $1,001 - $15,000 | 06/13/2024 | 05/03/2024 | |
$477.87 | Sale | $1,001 - $15,000 | 06/14/2024 | 05/03/2024 |
A. The list of insiders at Vertex Pharmaceuticals Incorporated includes Atkinson Edward Morrow III, Biller Jonathan, Sachdev Amit, Tatsis Ourania, LEIDEN JEFFREY M, ALTSHULER DAVID, Arbuckle Stuart A, Ambrose Kristen, Bhatia Sangeeta N., Kewalramani Reshma, SACHS BRUCE I, WAGNER CHARLES F JR, Bozic Carmen.
A. Insiders have sold a total of 108,511 Vertex Pharmaceuticals Incorporated shares in the last 12 months for a total of 47.38 M sold.
A. The following insiders have sold Vertex Pharmaceuticals Incorporated shares in the last 12 months: Atkinson Edward Morrow III ($5.09 M), Biller Jonathan ($727,822), Sachdev Amit ($5.78 M), Tatsis Ourania ($3.67 M), LEIDEN JEFFREY M ($5.20 M), ALTSHULER DAVID ($4.78 M), Arbuckle Stuart A ($5.71 M), Ambrose Kristen ($476,453), Bhatia Sangeeta N. ($188,178), Kewalramani Reshma ($7.51 M), SACHS BRUCE I ($3.17 M), WAGNER CHARLES F JR ($2.97 M), Bozic Carmen ($2.11 M),
A. The list of congress member trading at Vertex Pharmaceuticals Incorporated includes Tommy Tuberville.